156.62 USD
↘ 0.28 (0.18%)LIVE (AS OF 03:15 PM EDT)
Shares of AstraZeneca PLC (AZN) are trading at $156.62. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 2, 2026.
Open?$156.76
High?$158.32
Low?$154.83
Prev. Close?$156.90
Volume?1.3M
Avg. Volume?3.0M
VWAP?$155.91
Rel. Volume?0.43x
Bid / Ask
Bid?$156.49 × 200
Ask?$156.58 × 100
Spread?$0.09
Midpoint?$156.54
Valuation & Ratios
Market Cap?243.3B
Shares Out?N/A
P/E Ratio?109.56
P/B Ratio?17.99
EPS?$1.43
Dividend?1.46%
Ex-Dividend?N/A
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?95
Momentum?6
Short Sent.?63
Piotroski F-Score?2/9Weak
Altman Z-Score?4.33Safe
Confidence?58%Low
Short InterestLow
Short Interest?2.1M
Days to Cover?1.0
Avg Daily Volume3.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?0.93Weak
Quick Ratio?0.76Weak
Cash Ratio?0.27Low
Debt/Equity?1.40Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?109.6PRICEY▾
Peers22
S&P3
P/B?17.99HIGH▾
Peers33
S&P9
P/S?10.11HIGH▾
Peers27
S&P8
P/FCF?107.0PRICEY▾
Peers11
S&P3
EV/EBITDA?48.5HIGH▾
Peers11
S&P3
EV/Sales?10.74HIGH▾
Peers27
S&P9
Returns & Efficiency
ROE?16.4%STRONG▾
Peers44
S&P58
ROA?3.5%FAIR▾
Peers44
S&P31
Cash Flow & Enterprise
FCF?$2.3B
Enterprise Value?$258.4B
Fundamentals ratios updated end of day